Le Lézard
Classified in: Health, Science and technology
Subject: FDA

VeraSci Receives FDA Grant to Support Qualification of the Virtual Reality Functional Capacity Assessment Tool (VRFCAT)

DURHAM, N.C., Sept. 5, 2019 /PRNewswire/ -- VeraSci, a leading provider of innovative scientific and biotechnology services, announced today that they have received an FDA grant to conduct further research on the VRFCAT, their proprietary functional capacity assessment. The VRFCAT has recently been accepted into the FDA's COA Qualification Program as a measure of functional capacity for schizophrenia treatment trials. This project will use qualitative research methods to establish the clinical meaningfulness of this measure to patients, family members, and peer support specialists. Qualitative evidence supporting the clinical meaningfulness of the VRFCAT from patient and caregiver perspectives will help advance the VRFCAT through the FDA qualification process and is a key component of interest for payers and health care providers.

VeraSci logo (PRNewsfoto/VeraSci)

The VRFCAT is an eCOA task that simulates key instrumental activities of daily living (iADLS) in a realistic and interactive virtual environment. With demonstrated sensitivity to accepted measures of cognitive and functional deficits in multiple CNS disorders, the VRFCAT was developed in VeraSci's Innovation Lab to improve clinical trials by detecting functionally meaningful improvements in patients' everyday lives. The VRFCAT has numerous advantages over conventional assessments, and meets the highest psychometric standards, with strong support from industry sponsors, NIH and FDA as a functional co-primary outcome measure.

If you are interested in learning more about or demoing the VRFCAT, visit https://verasci.com/vrfcat/.

About VeraSci

Founded in 2004, VeraSci has a worldwide presence in clinical trial development, clinical and cognitive assessment and language services. VeraSci brings deep expertise, strategic innovation and unwavering commitment to every project, allowing each client to deliver data supporting innovative therapies.

For more information, press only:
PR Contact Name: Ashley Davis, Marketing Communications Manager
Phone number: 919-401-4642
Email: ashley.davis@verasci.com
Website: www.VeraSci.com


These press releases may also interest you

at 23:24
Fight to Fame, whose "BMS" Model (that's Blockchain + Movies + Sports) stands to create a new way forward for entertainment at large, with a Reality TV show launching in 2020 which plans to have 13 episodes filmed around the world. Currently in...

at 23:01
Frost & Sullivan has recognised Singtel with five awards at this year's Frost & Sullivan Asia-Pacific Best Practices Awards. Singtel was named Asia Pacific Secure IoT Service Provider of the Year, Southeast Asia Managed Security Service Provider of...

at 23:01
ACL Airshop, a technology-driven market leader in products, services, and ULD logistics and leasing solutions for the global air cargo industry, has recently promoted four key executives to senior leadership positions....

at 23:00
Check out The HOTH's YouTube channel to get fresh, awesome video content filled with the latest and greatest digital marketing strategies, tips and advice from the world's leading SEO experts. The HOTH's YouTube subscribers are always the first to...

at 22:25
Lumentum Holdings Inc. ("Lumentum") today announced the pricing of $900 million aggregate principal amount of convertible senior notes due 2026 (the "notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the...

at 22:25
On Saturday, December, 2019, Fat Joe ? Billboard Latin Music Award-winning artist and Market America | SHOP.COM's President of Urban and Latino Development ? released his 11th and final studio album, Family Ties. To celebrate, the Market America...

News published on 5 september 2019 at 10:15 and distributed by: